{"organizations": [], "uuid": "2f1370613475675dd045477709c3fb50ff9b44f2", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180514.html", "section_title": "Archive News &amp; Video for Monday, 14 May 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-evoke-pharma-posts-loss-of-013-per/brief-evoke-pharma-posts-loss-of-0-13-per-share-in-q1-idUSASC0A1VP", "country": "US", "domain_rank": 408, "title": "BRIEF-Evoke Pharma Posts Loss Of $0.13 Per Share in Q1", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-05-14T18:37:00.000+03:00", "replies_count": 0, "uuid": "2f1370613475675dd045477709c3fb50ff9b44f2"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-evoke-pharma-posts-loss-of-013-per/brief-evoke-pharma-posts-loss-of-0-13-per-share-in-q1-idUSASC0A1VP", "ord_in_thread": 0, "title": "BRIEF-Evoke Pharma Posts Loss Of $0.13 Per Share in Q1", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "evoke pharma inc", "sentiment": "negative"}, {"name": "nda", "sentiment": "none"}, {"name": "thomson reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "May 14 (Reuters) - Evoke Pharma Inc:\n* EVOKE PHARMA REPORTS FIRST QUARTER 2018 RESULTS AND HIGHLIGHTS\n* Q1 LOSS PER SHARE $0.13 * Q1 EARNINGS PER SHARE VIEW $-0.19 — THOMSON REUTERS I/B/E/S\n* NDA SUBMISSION FOR GIMOT ON TRACK FOR Q2 OF 2018 * INCLUDED IN NET LOSS FOR Q1 WAS A GAIN OF ABOUT $433,000 DUE TO CHANGE IN FAIR VALUE OF WARRANT LIABILITY Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)\nOur Standards: The Thomson Reuters Trust Principles. 0 : 0 narrow-browser-and-phone medium-browser-and-portrait-tablet landscape-tablet medium-wide-browser wide-browser-and-larger medium-browser-and-landscape-tablet medium-wide-browser-and-larger above-phone portrait-tablet-and-above above-portrait-tablet landscape-tablet-and-above landscape-tablet-and-medium-wide-browser portrait-tablet-and-below landscape-tablet-and-below Apps Newsletters Reuters Plus Advertising Guidelines Cookies Terms of Use Privacy\nAll Quote: s delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.\n© 2018 Reuters. All Rights Reserved.", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-05-14T18:37:00.000+03:00", "crawled": "2018-05-15T13:52:17.007+03:00", "highlightTitle": ""}